GSK plc Revenue

GSK plc had revenue of 7.99B GBP in the quarter ending June 30, 2025, with 1.29% growth. This brings the company's revenue in the last twelve months to 31.63B, up 0.59% year-over-year. In the year 2024, GSK plc had annual revenue of 31.38B with 3.46% growth.

Revenue (ttm)

31.63B

Revenue Growth

+0.59%

P/S Ratio

1.89

Revenue / Employee

460.90K

Employees

68,629

Market Cap

59.81B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	31.38B	1.05B	3.46%
Dec 31, 2023	30.33B	1.00B	3.42%
Dec 31, 2022	29.32B	4.63B	18.74%
Dec 31, 2021	24.70B	342.00M	1.40%
Dec 31, 2020	24.35B	-9.40B	-27.85%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
AstraZeneca	41.24B
Haleon	11.02B
Smith & Nephew	4.33B
ConvaTec Group	1.72B
Hikma Pharmaceuticals	2.35B
HUTCHMED (China)	439.54M
Genus	672.80M
Oxford Nanopore Technologies	204.69M

Revenue Rankings

GSK plc News

4 days ago - GSK plc (GSK) plc Presents at Bank of America Global Healthcare Conference 2025 Transcript - Seeking Alpha
4 days ago - Pi Health to Collaborate with GSK to Enhance Clinical Research Services - Business Wire
5 days ago - GSK Seeks FDA Approval to Expand Leucovorin Use - GuruFocus
5 days ago - GSK to seek a label update for leucovorin as FDA says it can cure autism - Seeking Alpha
6 days ago - GSK to submit label update for Leucovorin at FDA's request, does not intend to market it for autism - CNBC
6 days ago - FDA approves drug that Trump due to suggest as autism treatment - Reuters
6 days ago - Here's Why GSK (GSK) is a Strong Growth Stock - Nasdaq
8 days ago - GSK spin-off Haleon eyes Tylenol takeover - This is Money

More News